Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia

出版年份 2015 全文链接

标题

作者

关键词

出版物

Volume 125, Issue 20, Pages 3128-3132

出版商

American Society of Hematology

发表日期

2015-04-03

DOI

10.1182/blood-2015-01-621391

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now